<DOC>
	<DOCNO>NCT01728103</DOCNO>
	<brief_summary>The objective study obtain female first-catch urine , vaginal , cervical endocervical swab test multiple APTIMA Assays Gen-Probe PANTHER® TIGRIS® Systems .</brief_summary>
	<brief_title>Prospective Collection Female Specimens Testing With Gen-Probe APTIMA ( Registered Trademark ) Assays</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Gonorrhea</mesh_term>
	<mesh_term>Trichomonas Infections</mesh_term>
	<mesh_term>Chlamydia Infections</mesh_term>
	<criteria>The subject least 16 year age time enrollment currently sexually active ( penile/vaginal intercourse within past 12 month ) The subject and/or legally authorize representative willing undergo inform consent process prior study participation ( minor need document consent his/her parent legal guardian , unless site institutional review board [ IRB ] approve waiver parental consent minor ) In addition , subject must meet least one follow criterion : The subject report symptoms consistent suspect sexually transmissible infection ( STI ) abnormal discharge , genital itching , pain/discomfort sexual intercourse urination , and/or low abdominal discomfort Subject asymptomatic known partner , contact , person confirm suspect STI ( ) Subject asymptomatic undergoing screen evaluation possible STIs Subject asymptomatic undergoing routine examination pelvic examination The subject take antibiotic medication within last 21 day Subject already participate study Subject history illness principal investigator ( PI ) designee considers could interfere affect conduct , result , and/or completion clinical trial Subject history illness PI designee considers could create unacceptable risk subject enrol</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>